MILAN--18 Jun--PRNewswire--AsiaNet/InfoQuest - Results From Two Large, Multinational, Practice-Based Observational Studies in Blood Pressure New data announced today at the Annual European Society of Hypertension (ESH) show that measuring blood pressure in a doctor's office alone does not provide an accurate picture of a patient's blood pressure control. Treatments utilised only on this basis are likely to leave many people at increased risk of heart attack, stroke or even cardiovascular death. According to a further study also presented today, this "unnecessary" additional risk could be avoided by choosing a treatment regimen like once daily telmisartan, which provides smooth blood pressure control over a full 24 hour period, including the risky morning hours. Results from the SURGE hypertension study, an observational study of blood pressure control outside of a clinical setting, demonstrate that:(1,2) - More than 60% of patients do not have controlled (26,000 patients with hypertension (office blood pressure >140/90mmHg). Blood pressure control was measured using either HBPM (n=25,882) or ABPM (n= 863). The results(3,4) from this observational study, the largest practise-based study ever conducted in hypertension using this methodology, demonstrate that telmisartan provides powerful blood pressure control over a full 24-hour period, including the risky early morning hours(3,4): - The mean morning ABP was significantly reduced by telmisartan alone and in combination with HCTZ by -8.2/-4.9 mmHg (p